肿瘤相对于脾脏的位置是淋巴瘤患者的预后因素:来自REMARC试验的论证
本回顾性研究纳入REMARC队列301例弥漫大B细胞淋巴瘤患者,基于基线[18F]FDG PET/CT测量病灶相对于脾脏的分布特征(SpreadSpleen、Dspleen、sDspleen),评估其预后价值。结果显示这些特征可显著区分无进展生存和总生存的风险组,并与TMTV和IPI互补,整合后能改善生存预测。
要点
- 基于脾脏位置的病灶分布特征可独立将DLBCL患者分为两个风险组(P < 0.001)。
- 这些特征与TMTV和IPI互补,可联合将患者分为三个风险组(P < 0.001)。
- 将分布特征整合入基于TMTV和IPI的Cox模型可显著改善PFS和OS的C指数(P < 0.05)。
核心结论
- 基线PET/CT中描述肿瘤相对于脾脏播散和分布的特征强烈预测DLBCL患者的生存。
- 将这些特征与TMTV和IPI整合可进一步改善生存预测。
研究设计与样本
- 回顾性研究,纳入REMARC(NCT01122472)队列中的301例DLBCL患者,最终评估282例(平均年龄68.33 ± 5.41岁;男性164例)。
- 医师勾画肿瘤区域,脾脏采用开源人工智能算法自动分割,成功率为96%。
- 系统测量脾脏质心与所有其他病灶之间的距离,定义这些距离的标准差为病灶分布(SpreadSpleen),并计算每位患者脾脏与另一病灶间的最大距离(Dspleen),经体表面积归一化得到标准化Dspleen(sDspleen)。
- 通过单因素和多因素时间依赖Cox模型及Kaplan-Meier分析评估各PET/CT特征对无进展生存(PFS)和总生存(OS)的预测价值。
主要发现
- SpreadSpleen、Dspleen和sDspleen与TMTV不相关(Pearson ρ < 0.23),与IPI也不相关(Pearson ρ < 0.15)。
- 以中位值为截断值,SpreadSpleen、Dspleen和sDspleen均能将患者显著分为两个风险组,用于PFS和OS(P < 0.001)。
- 这些特征与TMTV和IPI互补,可将患者分为三个风险组,用于PFS和OS(P < 0.001)。
- 将SpreadSpleen、Dspleen或sDspleen整合入基于TMTV、IPI以及TMTV联合IPI的Cox模型,均显著改善PFS和OS的一致性指数(P < 0.05)。
关键数值与推荐
- 以中位值为截断值,SpreadSpleen、Dspleen和sDspleen均显著区分PFS和OS的两个风险组(P < 0.001)。
- 联合TMTV和IPI,这些特征可将患者分为三个风险组(P < 0.001)。
- 整合这些特征后Cox模型的一致性指数改善具有统计学意义(P < 0.05)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Baseline [18F]FDG PET/CT radiomic features can improve the survival prediction in patients with diffuse large B-cell lymphoma (DLBCL). The purpose of this study was to investigate whether characterizing tumor locations relative to the spleen location in baseline [18F]FDG PET/CT images predicts survival in patients with DLBCL and improves the predictive value of total metabolic tumor volume (TMTV) and age-adjusted international prognostic index (IPI). Methods: This retrospective study included 301 DLBCL patients from the REMARC (NCT01122472) cohort. Physicians delineated the tumor regions, whereas the spleen was automatically segmented using an open-access artificial intelligence algorithm. We systematically measured the distance between the centroid of the spleen and all other lesions, defining the SD of these distances as the lesion spread (SpreadSpleen). We calculated the maximum distance between the spleen and another lesion (Dspleen) for each patient and normalized it with the body surface area, resulting in standardized Dspleen (sDspleen). The predictive value of each PET/CT feature for progression-free survival (PFS) and overall survival (OS) was evaluated through univariate and multivariate time-dependent Cox models and Kaplan-Meier analysis. Results: In total, 282 patients (mean age, 68.33 ± 5.41 y; 164 men) were evaluated. The artificial intelligence algorithm successfully segmented the spleen in 96% of the patients. SpreadSpleen, Dspleen, and sDspleen were correlated neither with TMTV (Pearson ρ < 0.23) nor with IPI (Pearson ρ < 0.15). When median values were used as the cutoff, SpreadSpleen, Dspleen, and sDspleen all significantly classified patients into 2 risk groups for PFS and OS (P < 0.001). They complemented TMTV and IPI to classify the patients into 3 risk groups for PFS and OS (P < 0.001). Integrating SpreadSpleen, Dspleen, or sDspleen into a Cox model on the basis of TMTV, IPI, and TMTV combined with IPI significantly improved the concordance index for PFS and OS (P < 0.05). Conclusion: Baseline PET/CT features that characterize tumor spread and dissemination relative to the spleen strongly predicted survival in patients with DLBCL. Integrating these features with TMTV and IPI further improved survival prediction.
引用
- Girum KB, Cottereau AS, Vercellino L, et al. Tumor Location Relative to the Spleen Is a Prognostic Factor in Lymphoma Patients: A Demonstration from the REMARC Trial. J Nucl Med. 2024. PMID: 38071535. doi:10.2967/jnumed.123.266322
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。